---
title: "Lymphoma Clinical Trials in California"
description: "Find 1,212 clinical trials for lymphoma near California. Connect with research centers in your area."
url: "https://www.clareohealth.com/clinical-trials/condition/lymphoma/california"
---

# Lymphoma Clinical Trials in California

Find 1,212 clinical trials for lymphoma near California. Connect with research centers in your area.

- [All Lymphoma trials nationwide](https://www.clareohealth.com/clinical-trials/condition/lymphoma)
- [All trials in California](https://www.clareohealth.com/clinical-trials/location/california)

Showing 1-20 of 1,212 trials

### [Venetoclax and Romidepsin in Treating Patients With Recurrent or Refractory Mature T-Cell Lymphoma](https://www.clareohealth.com/clinical-trials/NCT03534180)

Status: COMPLETED · Phase: PHASE2 · NCT03534180 · Duarte, California and 1 other · Sponsor: City of Hope Medical Center

This phase II trial studies the side effects and best dose of venetoclax and romidepsin to see how well it works in treating patients with mature T-cell lymphoma that has come back…

### [A Randomized Phase IIb Placebo-Controlled Study of R-ICE Chemotherapy With and Without SGN-40 for Patients With DLBCL](https://www.clareohealth.com/clinical-trials/NCT00529503)

Status: TERMINATED · Phase: PHASE2 · NCT00529503 · Birmingham, Alabama and 65 others · Sponsor: Seagen Inc.

This is a randomized trial to estimate the activity of R-ICE plus SGN-40 vs. R-ICE plus placebo in patients with DLBCL.

### [Triplex Vaccine in Preventing CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplantation](https://www.clareohealth.com/clinical-trials/NCT04060277)

Status: ACTIVE_NOT_RECRUITING · Phase: PHASE2 · NCT04060277 · Duarte, California · Sponsor: City of Hope Medical Center

This phase II trial studies how well Triplex vaccine works in preventing cytomegalovirus (CMV) infection in patients undergoing a hematopoietic stem cell transplantation.

### [Study Evaluating the Safety and Effectiveness of ABT-510 in Subjects With Refractory Lymphoma](https://www.clareohealth.com/clinical-trials/NCT00061672)

Status: COMPLETED · Phase: PHASE2 · NCT00061672 · Phoenix, Arizona and 13 others · Sponsor: Abbott

The primary objective of this study is to assess the safety and effectiveness of ABT-510 in subjects with refractory lymphoma.

### [Fludarabine and Cyclophosphamide With or Without Rituximab Before CD19 Chimeric Antigen Receptor T Cells for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma](https://www.clareohealth.com/clinical-trials/NCT05052528)

Status: SUSPENDED · Phase: PHASE1 · NCT05052528 · Sacramento, California · Sponsor: University of California, Davis

This phase I trial evaluates the best dose, possible benefits and/or side effects of fludarabine and cyclophosphamide with or without rituximab before CD19 chimeric antigen recepto…

### [S0355 Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver Dysfunction](https://www.clareohealth.com/clinical-trials/NCT00049400)

Status: COMPLETED · Phase: PHASE1 · NCT00049400 · Duarte, California and 22 others · Sponsor: SWOG Cancer Research Network

RATIONALE: Drugs used in chemotherapy work in different ways to stop tumor cells from dividing so they stop growing or die.

### [The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients](https://www.clareohealth.com/clinical-trials/NCT00726934)

Status: COMPLETED · Phase: NA · NCT00726934 · San Diego, California and 5 others · Sponsor: Indiana University

The purpose of this study is to determine if FDA approved food safety guidelines are equivalent to a low bacterial diet (the neutropenic diet) with respect to the acquisition of in…

### [A Safety, Efficacy and Pharmacokinetics Study of CD11301 for the Treatment of Cutaneous T-Cell Lymphoma (CTCL)](https://www.clareohealth.com/clinical-trials/NCT03292406)

Status: COMPLETED · Phase: PHASE2 · NCT03292406 · Orange, California and 20 others · Sponsor: Galderma R&D

To assess the efficacy, safety and pharmacokinetics in participants treated with CD11301 gel vs. placebo for early stage CTCL (IA, IB, or IIA).

### [Vorinostat in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma and Liver Dysfunction](https://www.clareohealth.com/clinical-trials/NCT00499811)

Status: COMPLETED · Phase: PHASE1 · NCT00499811 · Duarte, California and 10 others · Sponsor: National Cancer Institute (NCI)

This phase I trial is studying the side effects and best dose of vorinostat in treating patients with metastatic or unresectable solid tumors or lymphoma and liver dysfunction.

### [A Study of PCI-32765 (Ibrutinib) in Combination With Either Bendamustine and Rituximab or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Participants With Previously Treated Indolent Non-Hodgkin Lymphoma](https://www.clareohealth.com/clinical-trials/NCT01974440)

Status: COMPLETED · Phase: PHASE3 · NCT01974440 · Gilbert, Arizona and 134 others · Sponsor: Janssen Research & Development, LLC

The purpose of this study is to evaluate the efficacy and safety of PCI-32765 (ibrutinib) administered in combination with either bendamustine and rituximab (BR) or rituximab, cycl…

### [S0016 Combination Chemotherapy With Monoclonal Antibody Therapy in Newly Diagnosed Non-Hodgkin's Lymphoma](https://www.clareohealth.com/clinical-trials/NCT00006721)

Status: COMPLETED · Phase: PHASE3 · NCT00006721 · Anchorage, Alaska and 258 others · Sponsor: SWOG Cancer Research Network

RATIONALE: Drugs used in chemotherapy work in different ways to stop cancer cells from dividing so they stop growing or die.

### [Genes in Predicting Outcome of Patients With DLBCL Treated With Rituximab and Combination Chemotherapy (R-CHOP)](https://www.clareohealth.com/clinical-trials/NCT00450385)

Status: TERMINATED · Phase: PHASE2 · NCT00450385 · Stanford, California and 4 others · Sponsor: University of Miami

The investigators hypothesize that survival of newly diagnosed DLBCL (diffuse large B-cell lymphoma) patients treated with R-CHOP can be predicted by RNA or protein gene expression…

### [Effect of Rituximab on Immunological Recall Response to Specific Antigens in the Treatment of Non-Hodgkin's Lymphoma](https://www.clareohealth.com/clinical-trials/NCT00090038)

Status: COMPLETED · Phase: PHASE4 · NCT00090038 · Los Angeles, California and 44 others · Sponsor: Biogen

The purpose of this study is to provide treatment for patients who have relapsed Non-Hodgkin's lymphoma (NHL) or refractory NHL, and to test the immunity of study subjects after re…

### [Ofatumumab and Bendamustine Hydrochloride With or Without Bortezomib in Treating Patients With Untreated Follicular Non-Hodgkin Lymphoma](https://www.clareohealth.com/clinical-trials/NCT01286272)

Status: COMPLETED · Phase: PHASE2 · NCT01286272 · La Jolla, California and 95 others · Sponsor: National Cancer Institute (NCI)

This randomized phase II trial studies how well ofatumumab and bendamustine hydrochloride with or without bortezomib works in treating patients with untreated follicular non-Hodgki…

### [Study To Evaluate Pf-04965842 In Subjects With Moderate To Severe Atopic Dermatitis](https://www.clareohealth.com/clinical-trials/NCT02780167)

Status: COMPLETED · Phase: PHASE2 · NCT02780167 · Birmingham, Alabama and 63 others · Sponsor: Pfizer

Study B7451006 is a Phase 2b POC study which is planned to assess four PF 04965842 once daily (QD) doses (10, 30, 100, 200 mg) relative to placebo over 12 weeks to characterize the…

### [Nivolumab With Standard of Care Chemotherapy for Peripheral T Cell Lymphomas](https://www.clareohealth.com/clinical-trials/NCT03586999)

Status: COMPLETED · Phase: PHASE1/PHASE2 · NCT03586999 · Duarte, California and 2 others · Sponsor: University of Colorado, Denver

This regimen aims to become the first line treatment for peripheral T cell lymphoma, using nivolumab with the standard of care chemotherapy.

### [Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Relapsed/Refractory Marginal Zone Lymphoma](https://www.clareohealth.com/clinical-trials/NCT01980628)

Status: COMPLETED · Phase: PHASE2 · NCT01980628 · Tucson, Arizona and 24 others · Sponsor: Pharmacyclics LLC.

Phase 2, open-label, non-randomized, monotherapy study to evaluate the safety and efficacy of ibrutinib in subject with relapsed/refractory Marginal Zone Lymphoma (MZL).

### [Study of an Investigational Drug, ASP3026, in Patients With Advanced Malignancies (Solid Tumors and B-Cell Lymphoma)](https://www.clareohealth.com/clinical-trials/NCT01284192)

Status: COMPLETED · Phase: PHASE1 · NCT01284192 · Orange, California and 5 others · Sponsor: Astellas Pharma Inc

This study is to evaluate the safety and anti-tumor activity of ASP3026 in patients with advanced malignancies (solid tumors and B-cell lymphoma).

### [A Study of INCB050465 in Relapsed or Refractory Mantle Cell Lymphoma Previously Treated With or Without a Bruton's Tyrosine Kinase (BTK) Inhibitor](https://www.clareohealth.com/clinical-trials/NCT03235544)

Status: COMPLETED · Phase: PHASE2 · NCT03235544 · Birmingham, Alabama and 102 others · Sponsor: Incyte Corporation

This is a Phase 2, open-label, 2-cohort study designed to evaluate the efficacy and safety of 2 parsaclisib treatment regimens in participants with relapsed or refractory mantle ce…

### [Trial of Intravenous Fenretinide Emulsion for Patients With Relapsed/Refractory Peripheral T-cell Lymphomas](https://www.clareohealth.com/clinical-trials/NCT02495415)

Status: UNKNOWN · Phase: PHASE2 · NCT02495415 · Gilbert, Arizona and 10 others · Sponsor: CerRx, Inc.

This study addresses the hypothesis that intermittent treatment with fenretinide intravenous emulsion will induce objective responses in patients with relapsed or refractory Periph…

## Lymphoma Trials in Other Cities

- [New York](https://www.clareohealth.com/clinical-trials/condition/lymphoma/new-york)
- [Los Angeles](https://www.clareohealth.com/clinical-trials/condition/lymphoma/los-angeles)
- [Chicago](https://www.clareohealth.com/clinical-trials/condition/lymphoma/chicago)
- [Houston](https://www.clareohealth.com/clinical-trials/condition/lymphoma/houston)
- [Phoenix](https://www.clareohealth.com/clinical-trials/condition/lymphoma/phoenix)
- [Philadelphia](https://www.clareohealth.com/clinical-trials/condition/lymphoma/philadelphia)

## Other Conditions in California

- [Breast Cancer](https://www.clareohealth.com/clinical-trials/condition/breast-cancer/california)
- [Lung Cancer](https://www.clareohealth.com/clinical-trials/condition/lung-cancer/california)
- [Prostate Cancer](https://www.clareohealth.com/clinical-trials/condition/prostate-cancer/california)
- [Colorectal Cancer](https://www.clareohealth.com/clinical-trials/condition/colorectal-cancer/california)
- [Melanoma](https://www.clareohealth.com/clinical-trials/condition/melanoma/california)
- [Leukemia](https://www.clareohealth.com/clinical-trials/condition/leukemia/california)

Data from [ClinicalTrials.gov](https://clinicaltrials.gov).

---

## Sitemap

This is the Markdown version of https://www.clareohealth.com/clinical-trials/condition/lymphoma/california.

- [Home](https://www.clareohealth.com/index.md)
- [About](https://www.clareohealth.com/about.md)
- [Pricing](https://www.clareohealth.com/pricing.md)
- [For providers](https://www.clareohealth.com/providers.md)
- [FAQ](https://www.clareohealth.com/faq.md)
- [Blog](https://www.clareohealth.com/blog.md)
- [Clinical trials](https://www.clareohealth.com/clinical-trials.md)
- [Developers](https://www.clareohealth.com/developers.md)
- [Privacy policy](https://www.clareohealth.com/legal/privacy-policy.md)
- [Terms of service](https://www.clareohealth.com/legal/terms-of-service.md)
- [Every page](https://www.clareohealth.com/sitemap.md)
- [About this site, for agents](https://www.clareohealth.com/llms.txt)
